Play all audios:
You have full access to this article via your institution. Download PDF FRANCE'S BIOMEDICAL AGENCY LAUNCHES PLAN TO COMBAT MISCONDUCT paris France's national biomedical research
agency, Inserm, has set up a Delegation of Scientific Integrity charged with “evaluating the reality of allegations of bad scientific conduct” and making recommendations for dealing with the
problem. The new body will consist of a national scientific committee and local ‘mediators’. The delegation will be headed by Martine Bungener, head of the agency's Laboratory of
Medicine, Science, Health and Society, and will be able to call in international experts if needed. The delegation has also been charged with liaising with similar European bodies to come up
with recommendations to promote “professional ethics of scientific publication”. Inserm has also launched a scheme to encourage ‘good practice guidelines’ in its laboratories, to “assure
the quality, traceability and integrity of data”. The move follows widespread criticism of the agency's handling of allegations of misconduct at one of its laboratories. It failed to
carry out its own investigation of the affair, while the science ministry — apparently unenthusiastic from the outset — quietly dropped the issue (see _ Nature_ 391, 519–520; 1998). The
French public prosecutor subsequently opened a formal judicial inquiry into the allegations. SENATORS ATTACK BUDGET CUT FOR MILITARY RESEARCH washington Nine US senators have written to
William Cohen, the defence secretary, objecting to administration plans to cut funding for military research and development by six per cent next year. The senators, who include prominent
figures from both parties, complain that military research spending has already fallen by 30 per cent in the past six years. The senators say it is short-sighted of the administration to
boost general military spending next year while cutting research and development still further. They point out that half of the US Nobel prizewinners in physics or chemistry since 1950 have
been funded by the Department of Defense. RUSSIA BEGINS TESTS ON ‘GLOBE’ TOKAMAK st petersburg Russian scientists have embarked on experiments to generate and maintain a high-temperature
plasma in the small spherical ‘Globus M’ tokamak reactor in St Petersburg. The experiments have been paid for by Japan and the European Union. The reactor, which resembles a giant globe and
weighs five tonnes, was built at a St Petersburg aircraft works as part of a programme to convert military facilities to civilian use. An additional US$150,000 has been allocated to continue
the project beyond the initial ignition stage. JAPAN GETS SET TO BUILD ITS OWN SPY SATELLITES tokyo Japan will be able to rely entirely on domestic technology to develop reconnaissance
satellites, chief cabinet secretary Hiromu Nonaka announced last week. The satellites, scheduled to be launched by 2002, are intended to improve the nation's ability to gather security
information following last year's firing of a North Korean missile over Japanese territory. Because of Japan's lack of experience in developing such satellites, the ruling Liberal
Democratic Party had considered seeking technological help from the United States (see _Nature_ 396, 401; 1998 ). But the government now says the National Space Development Agency will be
able to provide the required technology. US GRANTS FOR WORK ON LARGE HADRON COLLIDER washington Northeastern University in Boston, Massachusetts, has received a $20 million grant to lead US
university participation in the design and construction of the Compact Muon Spectrometer, one of the two particle detectors at Europe's Large Hadron Collider (LHC). The five-year grant
from the National Science Foundation is the largest element of the $80 million that the foundation will spend to support university scientists involved in LHC construction. It goes to
Stephen Reucroft of Northeastern's physics department, who will collaborate with groups at eight other physics departments. The US Department of Energy is already supporting scientists
at its laboratories who are participating in the construction of the muon spectrometer and of ATLAS, the other LHC detector. CHINA RECEIVES FUNDS TO PHASE OUT USE OF CFCS london China, the
world's largest producer of chlorofluorocarbons (CFCs), is to be given US$150 million to close down its CFC-producing facilities over the next 10 years. The amount was approved at the
end of last month by the committee that administers the Multilateral Fund of the Montreal Protocol on substances that deplete the ozone layer. The committee also agreed to give an additional
$30 million for projects that phase out CFC-production in other developing countries. It also approved a $7 million contribution to that end from the United Nations Environment Programme.
More than $900 million have now been spent on such projects. RESEARCH REACTOR GETS GO-AHEAD IN AUSTRALIA sydney Australia's environment minister, Robert Hill, gave his approval last
week to the construction of a research reactor to replace the HIFAR model operated for 40 years by the Australian Nuclear Science and Technology Organization (ANSTO) at Lucas Heights, an
outer suburb of Sydney. The decision followed satisfactory assessments of the project's likely environmental impact by three external bodies and Hill's department after the project
was approved in principle by the cabinet 19 months ago, subject to a satisfactory outcome (see _Nature_ 389, 109; 1997). A final go-ahead from science minister Nick Minchin to call
contracts for the pool-type reactor is expected shortly. At a total cost of A$300 million the reactor will be by far the largest public investment in a science and technology facility in
Australia. Construction is due start in 2002, with operational replacement and decommissioning of the old reactor in 2005. DNA CHIPS ‘BRING RISK OF GENETIC DISCRIMINATION’ london DNA chip
technology could lead to genetic discrimination, even eugenics, unless appropriate regulations are put in place, according to a paper in the _ Journal of Medical Ethics_ (25, 200-203; 1999).
According to Wolfram Henn of the Institute of Human Genetics in Homburg-Saar, Germany, DNA chip technology will be capable of analysing an individual's genetic make-up within a few
years. “It is a blessing for clinical medicine,” Henn writes. But it also “provides employers and insurers with ethically questionable parameters for aptitude tests”. US BILL OFFERS TAX
BREAKS FOR DEVELOPING VACCINES washington US politicians are seeking a tax break for companies working on vaccines against tuberculosis, malaria and HIV. A new bill would provide a 30 per
cent research and development tax credit for research into vaccines against any disease that kills more than one million people a year, and for work on developing microbicides. The bill was
introduced in the House of Representatives by Congresswoman Nancy Pelosi (Democrat, San Francisco) and Congressman Charles Rangel (Democrat, New York). A Senate companion bill is expected to
be introduced by John Kerry (Democrat, Massachusetts). RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE News in Brief. _Nature_ 398, 454 (1999).
https://doi.org/10.1038/18953 Download citation * Issue Date: 08 April 1999 * DOI: https://doi.org/10.1038/18953 SHARE THIS ARTICLE Anyone you share the following link with will be able to
read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing
initiative